KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume → Does this chart look familiar? (From InvestorPlace) (Ad) Free KALV Stock Alerts $12.00 -0.08 (-0.66%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability KalVista Pharmaceuticals Short Interest DataCurrent Short Volume5,540,000 sharesPrevious Short Volume5,820,000 sharesChange Vs. Previous Month-4.81%Dollar Volume Sold Short$62.88 millionShort Interest Ratio / Days to Cover7.4Last Record DateApril 30, 2024Outstanding Shares42,190,000 sharesPercentage of Shares Shorted13.13%Today's Trading Volume206,932 sharesAverage Trading Volume663,668 sharesToday's Volume Vs. Average31% Short Selling KalVista Pharmaceuticals ? Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKALV Short Interest Over TimeKALV Days to Cover Over TimeKALV Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. KalVista Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35 4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74 3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86 3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93 2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65 2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76 Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77 1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96 12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25 12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68 11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44 11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69 10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49 10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08 9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63 9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82 8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85 8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81 7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10 7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64 6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00 6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63 5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75 5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11 4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53 4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91 3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86 3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45 2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33 2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73 1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96 1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10 12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76 12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72 11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39 11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22 10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07 10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56 9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51 9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. KALV Short Interest - Frequently Asked Questions What is KalVista Pharmaceuticals' current short interest? Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 5,540,000 shares of KALV short. Learn More on KalVista Pharmaceuticals' current short interest. What is a good short interest ratio for KalVista Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 7.0. Learn More on KalVista Pharmaceuticals's short interest ratio. Is KalVista Pharmaceuticals' short interest increasing or decreasing? KalVista Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 5,540,000 shares, a drop of 4.8% from the previous total of 5,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does KalVista Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to KalVista Pharmaceuticals: Travere Therapeutics, Inc. (16.83%), Altimmune, Inc. (31.47%), Oculis Holding AG (0.20%), Verve Therapeutics, Inc. (30.19%), Shattuck Labs, Inc. (4.29%), Larimar Therapeutics, Inc. (6.11%), Adlai Nortye Ltd. (0.03%), COMPASS Pathways plc (4.99%), Arbutus Biopharma Co. (3.08%), Astria Therapeutics, Inc. (10.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short KalVista Pharmaceuticals stock? Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KalVista Pharmaceuticals? A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further. How often is KalVista Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TVTX Short Squeeze ALT Short Squeeze OCS Short Squeeze VERV Short Squeeze STTK Short Squeeze LRMR Short Squeeze ANL Short Squeeze CMPS Short Squeeze ABUS Short Squeeze ATXS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALV) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsHow Biden has already won 2024Porter & CompanyUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable Prosperity